0
Clinical Problem Solving: Pathology |

Pathology Quiz Case—Diagnosis

[+] Author Affiliations

Frederic B. Askin, MD
IndividualAuthor
William H. Westra, MD
IndividualAuthor

Copyright 2005 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

More Author Information
Arch Otolaryngol Head Neck Surg. 2005;131(1):82-82. doi:10.1001/archotol.131.1.82
Text Size: A A A
Published online
Figures in this Article

DIAGNOSIS: NASAL JUVENILE XANTHOGRANULOMA (JXG)

Juvenile xanthogranuloma was first described in 1905 by Adamson,1 who noted multiple yellow cutaneous papules that eventually regressed spontaneously in a 2-year-old boy. It is a benign histiocytic lesion that most often involves the head and neck region, followed by the trunk, upper extremities, and lower extremities, respectively.2 It usually presents as single or multiple yellow-orange to red-brown cutaneous lesions ranging in size from a few millimeters to several centimeters. Numerous extracutaneous sites within the head and neck region have been described, including the eye,3 oral cavity,4 temporal bone,5 nasopharynx,6 and larynx.7 The nasal cavity is an uncommon site of presentation, with few descriptions available in the English-language literature.4 ,8 9 Males are preferentially affected in the juvenile form (male-female ratio, 4:1), although a similar predilection does not exist in the adult form.2 The lesion is 10 times more common in whites than in blacks. Despite the nomenclature, JXG has been found to arise in both pediatric and adult populations, with presentations most often occurring in the first year and third decade of life.2 There is also a well-known association between JXG and neurofibromatosis 1 and acute myelogenous leukemia.10

Cutaneous lesions tend to be self-limited and undergo spontaneous involution. Frequently, no particular intervention is warranted. Surgical excision may be carried out for extracutaneous lesions if their location or size affects vital functions or if the diagnosis is in question. Some authors have advocated injected steroids and radiotherapy,11 although effectiveness is difficult to gauge given the self-limited nature of these lesions. Any patient diagnosed as having JXG should undergo full ophthalmologic examination because of the high predilection for ocular involvement.

Histopathologically, JXG presents as a well-circumscribed, dome-shaped lesion with a dense, diffuse dermal infiltrate, composed predominantly of histiocytes with admixed lymphocytes, eosinophils, neutrophils, and plasma cells, abutting the undersurface of the epidermis but not invading it (Figure 1 and Figure 2). The histopathologic hallmark is the Touton giant cell, a multinucleated giant histiocyte whose rings of nuclei separate a central homogeneous core from a foamy periphery. The number of Touton giant cells within the lesion and the prominence of the foamy periphery are variable. Early in the evolution of JXG, Touton giant cells may be either absent or sparse and, if present, their foamy periphery may not be well formed, as in the present case (Figure 3).12

Differential considerations include other histiocytic lesions, Rosai-Dorfman disease, and infectious causes. The primary non-Langerhans histiocytic lesion to consider in this type of case is reticulohistiocytoma. Reticulohistiocytoma, in contrast to JXG, lacks Touton giant cells at all stages of its evolution and characteristically is composed of large histiocytes with ground glass cytoplasm. Immunohistochemical analysis is not particularly helpful in differentiating between reticulohistiocytoma and JXG. Staining with antibodies, especially with macrophage markers (eg, CD68 and KP-1), is an ancillary technique and is only helpful to broadly classify the lesion as histiocytic in origin.13 Juvenile xanthogranuloma should also be differentiated from Langerhans histiocytosis. This distinction is facilitated with the use of immunohistochemical markers, because, unlike non-Langerhans lesions, Langerhans histiocytic lesions stain positive for S100 protein and CD1. This is an important distinction as Langerhans histiocytosis tends to be progressive in contrast to the non-Langerhans histiocytic disorders, which are usually self-limited in nature. Rosai-Dorfman disease and infection are other potential considerations in the differential diagnosis. Rosai-Dorfman disease, however, does not demonstrate the Touton giant cells typical of JXG and is characterized by lymphocytophagocytosis (emperipolesis) by sinus histiocytes, which are not a specific but a constant feature. The well-circumscribed, dome-shaped appearance of the lesion, the infiltrate abutting but not invading the overlying epidermis, and the presence of Touton giant cells, all of which are characteristic of JXG, ruled out an infectious origin in the present case.

Adamson  HG. A case of congenital xanthoma multiplex. Br J Dermatol 1905;17222
Tahan  SR, Paster-Levy  C, Bhan  K, Mihm  MC. Juvenile xanthogranuloma; clinical and pathologic characterization. Arch Pathol Lab Med 1989;1131057- 1061
PubMed
Zimmerman  LE. Ocular lesions of juvenile xanthogranuloma: nevoxanthoendothelioma. Am J Ophthalmol 1965;601011- 1035
PubMed
Saravanappa  N, Rashid  AMF, Thebe  PR, Davis  JP. Juvenile xanthogranuloma of the nasal cavity. J Laryngol Otol 2000;114460- 461
PubMed
Farrugia  EJ, Stephen  AP, Raza  SA. Juvenile xanthogranuloma of temporal bone—a case report. J Laryngol Otol 1997;11163- 65
PubMed
Batsakis  JG. Xanthogranuloma. Ann Otol Rhinol Laryngol 1989;98834- 835
PubMed
Sahhar  HS, Marra  S, Shahid  R, Akhter  J. Juvenile xanthogranuloma: a rare cause of subglottic cyst and stenosis. Ear Nose Throat J 2003;82725- 726
PubMed
Fang  TJ, Lin  CZ, Li  HY. Juvenile xanthogranuloma of the nasal cavity. Int J Pediatr Otorhinolaryngol 2003;67297- 299
PubMed
Aggarwal  K, Pahuja  S. Solitary intramuscular nasal juvenile xanthogranuloma: a case report with review of literature. Indian J Pathol Microbiol 2002;45359- 361
PubMed
Zvulunov  A, Barak  Y, Metzker  A. Juvenile xanthogranuloma, neurofibromatosis, and juvenile chronic myelogenous leukemia: world statistical analysis. Arch Dermatol 1995;131904- 908
PubMed
Casteels  I, Olver  J, Malone  M, Taylor  D. Early treatment of juvenile xanthogranuloma of the iris with subconjunctival steroids. Br J Ophthalmol 1993;7757- 60
PubMed
Kubota  Y, Kiryu  H, Nakayama  J, Koga  T. Histopathologic maturation of juvenile xanthogranuloma in a short period. Pediatr Dermatol 2001;18127- 130
PubMed
Tomaszewski  MM, Lupton  GP. Unusual expression of S-100 protein in histiocytic neoplasms. J Cutan Pathol 1998;25129- 135
PubMed

First Page Preview

First page PDF preview

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Adamson  HG. A case of congenital xanthoma multiplex. Br J Dermatol 1905;17222
Tahan  SR, Paster-Levy  C, Bhan  K, Mihm  MC. Juvenile xanthogranuloma; clinical and pathologic characterization. Arch Pathol Lab Med 1989;1131057- 1061
PubMed
Zimmerman  LE. Ocular lesions of juvenile xanthogranuloma: nevoxanthoendothelioma. Am J Ophthalmol 1965;601011- 1035
PubMed
Saravanappa  N, Rashid  AMF, Thebe  PR, Davis  JP. Juvenile xanthogranuloma of the nasal cavity. J Laryngol Otol 2000;114460- 461
PubMed
Farrugia  EJ, Stephen  AP, Raza  SA. Juvenile xanthogranuloma of temporal bone—a case report. J Laryngol Otol 1997;11163- 65
PubMed
Batsakis  JG. Xanthogranuloma. Ann Otol Rhinol Laryngol 1989;98834- 835
PubMed
Sahhar  HS, Marra  S, Shahid  R, Akhter  J. Juvenile xanthogranuloma: a rare cause of subglottic cyst and stenosis. Ear Nose Throat J 2003;82725- 726
PubMed
Fang  TJ, Lin  CZ, Li  HY. Juvenile xanthogranuloma of the nasal cavity. Int J Pediatr Otorhinolaryngol 2003;67297- 299
PubMed
Aggarwal  K, Pahuja  S. Solitary intramuscular nasal juvenile xanthogranuloma: a case report with review of literature. Indian J Pathol Microbiol 2002;45359- 361
PubMed
Zvulunov  A, Barak  Y, Metzker  A. Juvenile xanthogranuloma, neurofibromatosis, and juvenile chronic myelogenous leukemia: world statistical analysis. Arch Dermatol 1995;131904- 908
PubMed
Casteels  I, Olver  J, Malone  M, Taylor  D. Early treatment of juvenile xanthogranuloma of the iris with subconjunctival steroids. Br J Ophthalmol 1993;7757- 60
PubMed
Kubota  Y, Kiryu  H, Nakayama  J, Koga  T. Histopathologic maturation of juvenile xanthogranuloma in a short period. Pediatr Dermatol 2001;18127- 130
PubMed
Tomaszewski  MM, Lupton  GP. Unusual expression of S-100 protein in histiocytic neoplasms. J Cutan Pathol 1998;25129- 135
PubMed

Correspondence

CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles
Solitary retrovesical lesion in a newborn.
J Pediatr Hematol Oncol. 2012;34(2):159, 160-1.